Background: The progesterone (P4) metabolite, 5α-pregnan-3α-ol-20-one (3α,5α-THP), acts in the midbrain ventral tegmental area (VTA) to modulate the intensity and duration of lordosis. 3α,5α-THP can also have anti-anxiety and anti-stress effects in part through actions in the hippocampus. Separate reports indicate that manipulating 3α,5α-THP levels in the VTA or hippocampus respectively can influence lordosis and affective behavior. 3α,5α-THP levels can also be altered by behavioral experiences, such as mating or swim stress. Whether endogenous levels of 3α,5α-THP modulate and/or are increased in response to affective and/or reproductively-relevant behaviors was investigated. Methods: In Experiment 1, rats in behavioral estrus or diestrus were individually tested sequentially in the open field, elevated plus maze, partner preference, social interaction, and paced mating tasks and levels of 17β-estradiol (E2), P4, dihydroprogesterone (DHP), and 3α,5α-THP in serum, midbrain, hippocampus, diencephalon, and cortex were examined. In Experiments 2 and 3, rats in behavioral estrus or diestrus, were individually tested in the battery indicated above, with, or without, paced mating and tissues were collected immediately after testing for later assessment of endocrine measures. Results: In Experiment 1, behavioral estrous, compared to diestrous, rats demonstrated more exploratory, anti-anxiety, social, and reproductive behaviors, and had higher levels of E2 and progestins in serum, midbrain, hippocampus, diencephalon, and cortex. In Experiment 2, in midbrain and hippocampus, levels of 3α,5α-THP and its precursor DHP were increased among rats in behavioral estrus that were mated. In diencephalon, and cortex, DHP levels were increased by mating. In Experiment 3, in midbrain, levels of 3α,5α-THP and its precursor DHP were increased among diestrous rats that were tested in the behavioral battery with mating as compared to those tested in the behavioral battery without mating. Conclusions: Increased levels of 3α,5α-THP in behavioral estrus versus diestrous rats are associated with enhanced exploratory, anti-anxiety, social, and reproductive behaviors. Rats in behavioral estrus that are mated have further increases in 3α,5α-THP and/or DHP levels in midbrain, hippocampus, diencephalon, and cortex than do non-mated rats in behavioral estrus, whereas diestrous rats only show 3α,5α-THP increases in midbrain in response to behavioral testing that included mating.

Keywords:
Progesterone, 3α,5α-THP, Lordosis, GABAA receptor, Ventral tegmental area, Social behavior, affect
1.
Etgen AM: Progestin receptors and the activation of female reproductive behavior: a critical review. Horm Behav 1984;18:411–430.
2.
Rubin BS, Barfield RJ: Induction of estrous behavior in ovariectomized rats by sequential replacement of estrogen and progesterone to the ventromedial hypothalamus. Neuroendocrinology 1983;37:218–224.
3.
Rubin BS, Barfield RJ: Progesterone in the ventromedial hypothalamus facilitates estrous behavior in ovariectomized, estrogen-primed rats. Endocrinology 1983;113:797–804.
4.
Pleim ET, Lisciotto CA, DeBold JF: Facilitation of sexual receptivity in hamsters by simultaneous progesterone implants into the VMH and ventral mesencephalon. Horm Behav 1990;24:139–151.
5.
Frye CA: The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Brain Res Rev 2001;37:201–222.
6.
Frye CA, Petralia SM: 3α,5α-THP’s actions in the ventral tegmental area for lordosis: A model system for defining mechanisms and function of progestins; in Smith SS (ed): Neurosteroid Effects in the Central Nervous System: The Role of GABAA Receptor. Boca Raton, CRC Press, 2003, pp 265–289.
7.
Frye CA, Rhodes ME, Petralia SM, Walf AA, Sumida K, Edinger KL: 3α-Hydroxy-5α-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 2006;138:1007–1014.
8.
Frye CA, Petralia SM, Rhodes ME: Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3α,5α-THP. Pharmacol Biochem Behav 2000;67:587–596.
9.
Marcondes FK, Miguel KJ, Melo LL, Spadari-Bratfisch RC: Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol Behav 2001;74:435–440.
10.
Bitran D, Purdy RH, Kellogg CK: Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav 1993;45:423–428.
11.
Bitran D, Shiekh M, McLeod M: Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J Neuroendocrinol 1995;7:171–177.
12.
Frye CA, Walf AA: Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and pain-reducing effects in ovariectomized rats. Behav Neurosci 2004;118:306–313.
13.
Bitran D, Dugan M, Renda P, Ellis R, Foley M: Anxiolytic effects of the neuroactive steroid pregnanolone (3α-OH-5β-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res 1999;850:217–224.
14.
Akwa Y, Purdy RH, Koob GF, Britton KT: The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res 1999;106:119–125.
15.
Bitran D, Foley M, Audette D, Leslie N, Frye CA: Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl) 2000;151:64–71.
16.
Frye CA, Walf AA, Rhodes ME, Harney JP: Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase. Brain Res 2004;1004:116–124.
17.
Frye CA, Walf AA: Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002;41:306–315.
18.
Rhodes ME, Frye CA: Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors. Cogn Affect Behav Neurosci 2001;1:287–296.
19.
Holzbauer M: Physiological variations in the ovarian production of 5α-pregnane derivatives with sedative properties in the rat. J Steroid Biochem 1975;6:1307–1310.
20.
Holzbauer M, Godden U: Variations in the progesterone content of the rat adrenal gland during the oestrous cycle. J Steroid Biochem 1974;5:109–111.
21.
Karavolas HJ, Hodges DR: Neuroendocrine metabolism of progesterone and related progestins. Ciba Found Symp 1990;153:22–44.
22.
Karavolas HJ, Hodges D, Normand N, O’Brien D: Conversion of 17α-hydroxyprogesterone to 5α-, 3α-, and 20α-reduced metabolites by female rat anterior pituitary and hypothalamus. Steroids 1988;51:527–541.
23.
Baulieu EE, Schumacher M, Koenig H, Jung-Testas I, Akwa Y: Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol 1996;16:143–154.
24.
Jung-Testas I, Do Thi A, Koenig H, Desarnaud F, Shazand K, Schumacher M, Baulieu E: Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J Steroid Biochem Mol Biol 1999;69:97–107.
25.
Baulieu EE, Robel P, Schumacher M: Neurosteroids: beginning of the story. Int Rev Neurobiol 2001;46:1–32.
26.
Barbaccia ML, Roscetti G, Trabucchi M, Cuccheddu T, Concas A, Biggio G: Neurosteroids in the brain of handling-habituated and naive rats: effect of CO2 inhalation. Eur J Pharmacol 1994;261:317–320.
27.
Barbaccia ML, Roscetti G, Bolacchi F, Concas A, Mostallino MC, Purdy RH, Biggio G: Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol Biochem Behav 1996;54:205–210.
28.
Barbaccia ML, Roscetti G, Trabucchi M, Mostallino MC, Concas A, Purdy RH, Biggio G: Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology 1996;63:166–172.
29.
Drugan RC, Park R, Kaufman L, Holmes PV: Etiology of the sexual dimorphism in renal peripheral benzodiazepine receptor response to stress in rats. Horm Behav 1993;27:348–365.
30.
Erskine MS, Kornberg E: Stress and ACTH increase circulating concentrations of 3α-androstanediol in female rats. Life Sci 1992;51:2065–2071.
31.
Higashi T, Takido N, Shimada K: Studies on neurosteroids XVII. Analysis of stress-induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry. Steroids 2005;70:1–11.
32.
Purdy RH, Morrow AL, Moore PH Jr, Paul SM: Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 1991;88:4553–4557.
33.
Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX: Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006;138:749–756.
34.
Lan NC, Bolger MB, Gee KW: Identification and characterization of a pregnane steroid recognition site that is functionally coupled to an expressed GABAA receptor. Neurochem Res 1991;16:347–356.
35.
Frye CA, Bayon LE: Mating stimuli influence endogenous variations in the neurosteroids 3α,5α-THP and 3α-diol. J Neuroendocrinol 1999;11:839–847.
36.
Engel SR, Grant KA: Neurosteroids and behavior. Int Rev Neurobiol 2001;46:321–348.
37.
Frye CA, Petralia SM: Lordosis of rats is modified by neurosteroidogenic effects of membrane benzodiazepine receptors in the ventral tegmental area. Neuroendocrinology 2003;77:71–82.
38.
Frye CA, Vongher JM: Ventral tegmental area infusions of inhibitors of the biosynthesis and metabolism of 3α,5α-THP attenuate lordosis of hormone-primed and behavioural oestrous rats and hamsters. J Neuroendocrinol 2001;13:1076–1086.
39.
Petralia SM, Jahagirdar V, Frye CA: Inhibiting biosynthesis and/or metabolism of progestins in the ventral tegmental area attenuates lordosis of rats in behavioural oestrus. J Neuroendocrinol 2005;17:545–552.
40.
Frye CA: The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents. Horm Behav 2001;40:226–233.
41.
Frye CA, Vongher JM: GABAA, D1, and D5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis. Behav Brain Res 1999;103:23–34.
42.
Frye CA, Walf AA, Sumida K: Progestins’ actions in the VTA to facilitate lordosis involve dopamine-like type 1 and 2 receptors. Pharmacol Biochem Behav 2004;78:405–418.
43.
Reddy DS, Kulkarni SK: Role of GABAA and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl) 1996;128:280–292.
44.
Long JA, Evans HM: Oestrous cycle in the rat and its associated phenomena. Mem Univ Calif 1922;6:1–146.
45.
Edinger KL, Frye CA: Testosterone’s analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5α-reduced metabolites in the hippocampus. Behav Neurosci 2004;118:1352–1364.
46.
Blizard DA, Lippman HR, Chen JJ: Sex differences in open-field behavior in the rat: the inductive and activational role of gonadal hormones. Physiol Behav 1975;14:601–608.
47.
McCarthy MM, Felzenberg E, Robbins A, Pfaff DW, Schwartz-Giblin S: Infusions of diazepam and allopregnanolone into the midbrain central gray facilitate open-field behavior and sexual receptivity in female rats. Horm Behav 1995;29:279–295.
48.
Dunn RW, Reed TA, Copeland PD, Frye CA: The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology 1998;37:899–904.
49.
Baum M: Extinction of an avoidance response motivated by intense fear: social facilitation of the action of response prevention (flooding) in rats. Behav Res Ther 1969;7:57–62.
50.
File SE: The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 1980;2:219–238.
51.
Erskine MS: Effects of paced coital stimulation on estrus duration in intact cycling rats and ovariectomized and ovariectomized-adrenalectomized hormone-primed rats. Behav Neurosci 1985;99:151–161.
52.
Frye CA, Erskine MS: Influence of time of mating and paced copulation on induction of pseudopregnancy in cyclic female rats. J Reprod Fertil 1990;90:375–385.
53.
Hardy DF, DeBold JF: Effects of coital stimulation upon behavior of the female rat. J Comp Physiol Psychol 1972;78:400–408.
54.
Frye CA, Bayon LE, Pursnani NK, Purdy RH: The neurosteroids, progesterone and 3α,5α-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res 1998;808:72–83.
55.
Rodbard D, Hutt DM: Statistical analysis of radioimmunoassay and immunoradiometric assays: a generalized, weighted iterative, least squares method for logistic curve fitting; in International Atomic Energy Agency (ed): Symposium on Radioimmunoassay and Related Procedures in Medicine. New York, Uniput, 1974, pp 209–223.
56.
Zuluaga MJ, Agrati D, Pereira M, Uriarte N, Fernandez-Guasti A, Ferreira A: Experimental anxiety in the black and white model in cycling, pregnant and lactating rats. Physiol Behav 2005;84:279–286.
57.
Diaz-Veliz G, Butron S, Benavides MS, Dussaubat N, Mora S: Gender, estrous cycle, ovariectomy, and ovarian hormones influence the effects of diazepam on avoidance conditioning in rats. Pharmacol Biochem Behav 2000;66:887–892.
58.
Komisaruk BR, Diakow C: Lordosis reflex intensity in rats in relation to the estrous cycle, ovariectomy, estrogen administration and mating behavior. Endocrinology 1973;93:548–557.
59.
Frye CA, Rhodes ME: Infusions of 3α,5α-THP to the ventral tegmental area, but not substantia nigra, enhance exploratory, anti-anxiety, social, and sexual behaviours and concomitantly increase 3α,5α-THP concentrations in the hippocampus, diencephalon, and cortex of ovariectomized estrogen-primed rats. J Neuroendocrinol 2006 (in revision).
60.
Frye CA, Rhodes ME: Infusions of 3α,5α-THP to the VTA enhance exploratory, anti-anxiety, social, and sexual behavior and increase levels of 3α,5α-THP in midbrain, hippocampus, diencephalon, and cortex of female rats. Horm Behav 2006 (submitted).
61.
Frye CA, McCormick CM, Coopersmith C, Erskine MS: Effects of paced and non-paced mating stimulation on plasma progesterone, 3α-diol and corticosterone. Psychoneuroendocrinology 1996;21:431–439.
62.
Griffin LD, Mellon SH: Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 1999;96:13512–13517.
63.
Carter CS: Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology 1998;23:779–818.
64.
Lopez NL, Vazquez DM, Olson SL: An integrative approach to the neurophysiological substrates of social withdrawal and aggression. Dev Psychopathol 2004;16:69–93.
65.
McEwen BS: Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005;54:20–23.
66.
Vassout A, Veenstra S, Hauser K, Ofner S, Brugger F, Schilling W, Gentsch C: NKP608: A selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regul Pept 2000;96:7–16.
67.
Gans SE, Stamper JL, Butler T, McClintock MK: Endocrine basis for two types of individual differences in lordosis reflex intensity. Horm Behav 1995;29:367–391.
68.
Li X, Bertics PJ, Karavolas HJ: Regional distribution of cytosolic and particulate 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases in female rat brain. J Steroid Biochem Mol Biol 1997;60:311–318.
69.
Micevych P, Sinchak K, Mills RH, Tao L, LaPolt P, Lu JK: The luteinizing hormone surge is preceded by an estrogen-induced increase of hypothalamic progesterone in ovariectomized and adrenalectomized rats. Neuroendocrinology 2003;78:29–35.
70.
Cheng YJ, Karavolas HJ: Conversion of progesterone to 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one by rat medical basal hypothalami and the effects of estradiol and stage of estrous cycle on the conversion. Endocrinology 1973;93:1157–1162.
71.
Vongher JM, Frye CA: Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration. Pharmacol Biochem Behav 1999;64:777–785.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.